These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3758337)

  • 1. [Action of nonachlazine on the creatine phosphokinase and acid phosphatase activity and on the lysosomal membrane stability of the ischemic myocardium in rats after preliminary reserpinization].
    Sysoliatina NA
    Farmakol Toksikol; 1986; 49(4):77-81. PubMed ID: 3758337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of nonachlazine on the temperature sensitivity of the lysosomal membranes of the heart muscle in rats in vitro].
    Sysoliatina NA
    Farmakol Toksikol; 1985; 48(3):41-5. PubMed ID: 4029378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of isadrine and anaprilin on lysosomal membrane permeability of the ischemic myocardium].
    Prusachenko VK
    Farmakol Toksikol; 1981; 44(4):417-9. PubMed ID: 7286197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of beta-adrenomimetics on the degree of lysosomal membrane damage and glycogen phosphorylase activity of the ventricular myocardium of guinea pigs].
    Sysoliatina NA
    Farmakol Toksikol; 1988; 51(2):59-61. PubMed ID: 3378608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of the inotropic action of nonachlazine].
    Kaverina NV; Katsenovich RA; Tkachenko BI; Iunusov ZZ; Ovsiannikov VI
    Farmakol Toksikol; 1985; 48(1):23-7. PubMed ID: 3979531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of nonachlazine on systemic hemodynamics and the collateral coronary circulation in acute myocardial ischemia].
    Pilipchuk DB; Berger DIa; Sapozhkov AV
    Farmakol Toksikol; 1980; 43(3):324-7. PubMed ID: 7449970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
    Tereshchenko VP
    Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of nonachlazine on ATP, ADP, and lactic acid concentration in intact and ischemic myocardium].
    Turilova AI; Azvolinskaia TN; Kryzhanovskiĭ SA
    Biull Eksp Biol Med; 1980 Jul; 89(7):49-51. PubMed ID: 7407371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonachlazine in solution as an arresting agent in stenocardiac attacks].
    Boĭko SS; Kaverina NV; Liubimov BI; Markova GA; Mitrofanov VS
    Farmakol Toksikol; 1979; 42(3):243-7. PubMed ID: 446702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities for the external regulation of lysosomal structure and functions. Pharmacological effects on the permeability of lysosomal membranes in the ischemic myocardium].
    Sysoliatina NA; Sapozhkov AV
    Farmakol Toksikol; 1985; 48(2):121-3. PubMed ID: 2987027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of nonachlazine on the energy provision for cardiac contractile activity in experimental myocardial infarct].
    Reznikov KM; Provotorova PP; Sidel'nikova VI
    Farmakol Toksikol; 1982; 45(5):52-7. PubMed ID: 7140956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Creatine phosphokinase activity in myocardial sarcoplasmic reticulum membranes in experimental coronary insufficiency].
    Frol'kis RA; Voronkov GS; Dubur GIa; Tsiomik VA; Gomon IV
    Biull Eksp Biol Med; 1983 May; 95(5):53-5. PubMed ID: 6850090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of the effect of nonachlazine on the metabolism of the ischemic myocardium].
    Sysoliatina NA; Iakushev MP; Sapozhkov AV
    Biull Eksp Biol Med; 1982 Mar; 93(3):48-50. PubMed ID: 6284278
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of action of nonachlazine and ethmozine on the cardiac blood supply in acute myocardial ischemia].
    Pilipchuk DB
    Farmakol Toksikol; 1981; 44(1):63-7. PubMed ID: 7021174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of several membrane-bound creatine kinase isoenzymes in the rabbit myocardium in experimental disruption of coronary circulation].
    Voronkov GS
    Vopr Med Khim; 1984; 30(2):125-6. PubMed ID: 6740989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-inflammatory, analgesic and antipyretic properties of nonachlazine].
    Kaverina NV; Krupińska J; Pidevich IN; Sobański G; Demina LM
    Farmakol Toksikol; 1980; 43(3):317-9. PubMed ID: 6969665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors affecting the acid phosphatase activity of lysosomal membranes].
    Tsatsidze MA; Darchiia TK; Gegechkori MG; Gabuniia GD; Kotrikadze NG
    Izv Akad Nauk SSSR Biol; 1985; (6):923-6. PubMed ID: 4086700
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nonachlazine on brain and myocardial noradrenaline content in normal rats and rats subjected to stress].
    Turilova AI; Bendikov EA
    Biull Eksp Biol Med; 1981 May; 91(5):580-2. PubMed ID: 7260390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.